X0306 4 2021-05-03 0 0001809519 GoodRx Holdings, Inc. GDRX 0001822193 Azad Babak C/O GOODRX HOLDINGS, INC. 2701 OLYMPIC BOULEVARD SANTA MONICA CA 90404 0 1 0 0 See Remarks Class A Common Stock 2021-05-03 4 M 0 70833 5.94 A 70833 D Class A Common Stock 2021-05-03 4 S 0 66483 39.0771 D 4350 D Class A Common Stock 2021-05-03 4 S 0 4350 39.791 D 0 D Stock Option (Right to Buy) 5.94 2021-05-03 4 M 0 70833 0.00 D 2030-01-30 Class A Common Stock 70833 495417 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.67 to $39.66. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.67 to $40.02. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on October 9, 2019. Chief Marketing Officer and SVP, Marketing & Communications /s/ Gracye Cheng, as Attorney-in-Fact for Babak Azad 2021-05-03